Glenmark Pharma arm launches drug used to treat blood clotting issues

Share it

Glenmark Pharma Share Price | The newly-launched drug is bioequivalent and therapeutically equivalent to the reference listed drug, Vitamin K Injectable Emulsion USP, 10 mg/ml of Hospira, Inc.

Leave a Comment

Your email address will not be published. Required fields are marked *